0.51 Everest Medicines Announces China NMPA Recommends Priority Review for Nefecon for the Treatment of Primary IgA Nephropathy

News


<< back

Everest Medicines Announces China NMPA Recommends Priority Review for Nefecon for the Treatment of Primary IgA Nephropathy
Date: 2022-12-30 [news.yahoo.com]

READ THE FULL NEWS >>
×